6CT-79348-80944
3 vaccinations
7 coded responses
11 check-ins
5 free-text entries
2 call cases
- Sex
- Female
- Age at first dose
- 0-4
- ZIP prefix
- 685 / NE
- Registered
- 2022-07-23
- Relationship
- Child or adolescent in my care
- Guardian
- 7PG-49656-80881
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2022-07-12
Dose 1 — Moderna
-
2022-07-23
Registered in v-safe
- 2022-07-23
-
2022-07-26
Survey response — day 14, dose 1, under 3MedDRA: Cough, Pyrexia, Rhinorrhoea — Feeling: FairFree text: Cough (possibly due to teething), fever (presumably due to 6 month vaccines), runny noseMedDRA releases: 2024-11 · check-in free text available
- 2022-08-02
-
2022-08-09
Survey response — day 28, dose 1, under 3MedDRA: Teething — Feeling: FairFree text: TeethingMedDRA releases: 2024-11 · check-in free text available
-
2022-08-12
Dose 2 — Moderna
- 2022-09-14
-
2022-09-16
Survey response — day 35, dose 2, under 3MedDRA: Nasopharyngitis — Feeling: FairFree text: Cold symptomsMedDRA releases: 2024-11 · check-in free text available
-
2022-09-23
Survey response — day 42, dose 2, under 3MedDRA: Irritability, Nasopharyngitis, Rhinorrhoea, Teething — Feeling: FairFree text: Runny nose, fussiness, rubbing eyes (has a cold and is teething)MedDRA releases: 2024-11 · check-in free text available
-
2022-11-11
Survey response — 3 months, dose 2, under 3MedDRA: Ear infection, Nasopharyngitis, Respiratory syncytial virus infection — Feeling: Good · Be unable to work or attend school, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: RSV, ear infection, various coldsMedDRA releases: 2024-11 · check-in free text available
-
2022-11-11
Report sent to call center — 3 months, dose 2, under 3Be unable to work or attend school · Get care from a doctor or other healthcare professionalOutpatient clinic or urgent care clinic visit · 1 call case(s)
-
2022-11-14
Call successfulNot applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill
-
2022-12-30
Dose 3 — Moderna
-
2023-02-10
Survey response — 6 months, dose 2, under 3MedDRA: Fatigue, Pyrexia, Respiratory tract congestion — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activitiesMedDRA releases: 2024-11
-
2023-03-31
Survey response — 3 months, dose 3, under 3MedDRA: COVID-19, Febrile convulsion, Roseola — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Emergency room or emergency department visitMedDRA releases: 2024-11
-
2023-03-31
Report sent to call center — 3 months, dose 3, under 3Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prEmergency room or emergency department visit · 1 call case(s)
-
2023-04-03
Call successfulNot applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill
- 2023-06-30
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2022-07-12 | Moderna | No |
| 2 | 2022-08-12 | Moderna | No |
| 3 | 2022-12-30 | Moderna | No |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2022-11-11 | Successful 2022-11-14 |
Not applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill |
| 2023-03-31 | Successful 2023-04-03 |
Not applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill |
Free text
Release 12 (Under 3) — day 14, dose 1, under 3
Symptoms: Cough (possibly due to teething), fever (presumably due to 6 month vaccines), runny nose
Release 12 (Under 3) — day 28, dose 1, under 3
Symptoms: Teething
Release 12 (Under 3) — day 35, dose 2, under 3
Symptoms: Cold symptoms
Release 12 (Under 3) — day 42, dose 2, under 3
Symptoms: Runny nose, fussiness, rubbing eyes (has a cold and is teething)
Release 12 (Under 3) — 3 months, dose 2, under 3
Symptoms: RSV, ear infection, various colds
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Cough | · | · | ✓ |
| SD | COVID-19 | · | · | ✓ |
| SD | Ear infection | · | · | ✓ |
| SD | Fatigue | · | · | ✓ |
| SD | Febrile convulsion | · | · | ✓ |
| SD | Irritability | · | · | ✓ |
| SD | Nasopharyngitis | · | · | ✓ |
| SD | Pyrexia | · | · | ✓ |
| SD | Respiratory syncytial virus infection | · | · | ✓ |
| SD | Respiratory tract congestion | · | · | ✓ |
| SD | Rhinorrhoea | · | · | ✓ |
| SD | Roseola | · | · | ✓ |
| SD | Teething | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release